However, it is important to note that both medications may have side effects, including nausea and abdominal pain, which should be considered when evaluating treatment options
Lombardo P, Scuri R, Cataldo E, Calvani M, Nicolai R, Mosconi L, et al
David Greenwald, director of Clinical Gastroenterology and Endoscopy at Mount Sinai Hospital, who did not treat Hinderhan
The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources
Semaglutide is currently in phase 3 clinical testing
Despite the growing interest in these medications, there is also concern about their misuse